115 related articles for article (PubMed ID: 36039881)
21. Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.
Eldaly MN; Metwally FM; Shousha WG; El-Saiid AS; Ramadan SS
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1689-1695. PubMed ID: 32592365
[TBL] [Abstract][Full Text] [Related]
22. LncRNA KCNQ1OT1 acts as miR-216b-5p sponge to promote colorectal cancer progression via up-regulating ZNF146.
Zhu S; Chen CY; Hao Y
J Mol Histol; 2021 Jun; 52(3):479-490. PubMed ID: 33394291
[TBL] [Abstract][Full Text] [Related]
23. A panel of microRNA signature in serum for colorectal cancer diagnosis.
Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
[TBL] [Abstract][Full Text] [Related]
24. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
25. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients.
Duran-Sanchon S; Vila-Navarro E; Marcuello M; Lozano JJ; Muñoz J; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; Herreros-Villanueva M; Martín AC; Pérez-Palacios R; Arroyo R; Castells A; Gironella M
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877644
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs expression profiling in Egyptian colorectal cancer patients.
Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M
IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372
[TBL] [Abstract][Full Text] [Related]
27. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
Li L; Wang A; Cai M; Tong M; Chen F; Huang L
Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
[TBL] [Abstract][Full Text] [Related]
28. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
29. miR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma.
Luo M; Wu L; Zhang K; Wang H; Wu S; O'Connell D; Gao T; Zhong H; Yang Y
Cell Signal; 2018 Jan; 42():30-43. PubMed ID: 28982601
[TBL] [Abstract][Full Text] [Related]
30. MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway.
Chu CA; Lee CT; Lee JC; Wang YW; Huang CT; Lan SH; Lin PC; Lin BW; Tian YF; Liu HS; Chow NH
EBioMedicine; 2019 May; 43():270-281. PubMed ID: 30982765
[TBL] [Abstract][Full Text] [Related]
31. The role of miRNAs targeting K-ras and APC genes in colorectal cancer.
Yilmaz N; Yilmaz U; Tanbek K; Arikan S; Aksakal N; Zeybek U; Ergen A
Bratisl Lek Listy; 2020; 121(8):554-557. PubMed ID: 32726117
[TBL] [Abstract][Full Text] [Related]
32. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression.
Yu G; Xiong D; Liu Z; Li Y; Chen K; Tang H
J Cell Biochem; 2019 Oct; 120(10):17258-17272. PubMed ID: 31104316
[TBL] [Abstract][Full Text] [Related]
34. Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.
Basati G; Razavi AE; Pakzad I; Malayeri FA
Tumour Biol; 2016 Feb; 37(2):1781-8. PubMed ID: 26318304
[TBL] [Abstract][Full Text] [Related]
35. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
36. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
37. Investigation the Role of Autophagy in Non-Small Cell Lung Cancer.
Pargol M; Zare Karizi S; Akbari M; Nourmohammadi B; Shadmehr MB; Karimipoor M; Zare Karizi S
Asian Pac J Cancer Prev; 2021 Mar; 22(3):947-955. PubMed ID: 33773561
[TBL] [Abstract][Full Text] [Related]
38. Elevated serum miR-3129-5p contributes to the progression of coronary heart disease via targeting mTOR.
Wang ZY; Zhao T; Zhou J; Gao F
Kaohsiung J Med Sci; 2021 Apr; 37(4):314-323. PubMed ID: 33336524
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy.
Zhang X; Shi H; Lin S; Ba M; Cui S
Oncol Rep; 2015 Sep; 34(3):1557-64. PubMed ID: 26134156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
